Key Takeaways Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon simultaneously
These medications are intended for adults with obesity or overweight who have weight-related health issues
The take-home message for PCPs is the need to become educated on the different types of GLP-1 RAs, their different doses, and their different FDA-approved specific indications at the doses prescribed, he said
You should seek prompt medical advice if you are currently using unlicensed peptides and experience any of the following: Persistent nausea, vomiting, or severe abdominal pain (which may indicate pancreatitis) Unexplained changes in heart rate or palpitations Symptoms of hypoglycaemia , such as shakiness, sweating, confusion, or dizziness Injection site redness, swelling, or signs of infection Unusual lumps, swelling in the neck, or difficulty swallowing (which may indicate thyroid changes) Mood changes, anxiety, or psychological distress related to body image or supplement use For urgent medical advice, contact NHS 111 (online at 111.nhs.uk or by telephone)
Following this procedure ensures you start with a sterile, correctly concentrated, and undamaged solution